Italia markets closed

PerkinElmer, Inc. (PKI)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
138,56+3,60 (+2,67%)
Alla chiusura: 04:04PM EST
138,56 +0,02 (+0,01%)
Dopo ore: 04:07PM EST

PerkinElmer, Inc.

940 Winter Street
Waltham, MA 02451
United States
781 663 6900

SettoreDiagnostics & Research
Impiegati a tempo pieno16.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Dr. Prahlad R. Singh Ph.D.CEO, Pres & Director4,15M1,1M1965
Mr. Tajinder VohraSr. VP of Global Operations1,06MN/D1966
Mr. Joel S. GoldbergSr. VP of Admin., Gen. Counsel & Sec.1,53M2,91M1969
Mr. Daniel R. TereauSr. VP of Strategy & Bus. Devel.1,18M645,18k1968
Mr. Maxwell KrakowiakSr. VP & CFON/DN/D1989
Mr. Andrew OkunVP, Chief Accounting Officer & TreasurerN/DN/D1970
Mr. Stephen Barr WilloughbySr. VP of Investor Relations & Head of ESGN/DN/DN/D
Mr. Robert Francis FrielAdvisorN/DN/D1956
Ms. Miriame VictorSr. VP & Chief Commercial OfficerN/DN/D1981
Dr. Masoud Toloue Ph.D.Sr. VP of DiagnosticsN/DN/D1980
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Governance aziendale

L'ISS Governance QualityScore di PerkinElmer, Inc. al 1 gennaio 2023 è 8. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 6; diritti degli azionisti: 8; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.